We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Sigma Labs Inc | NASDAQ:SGLBW | NASDAQ | Equity Warrant |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.0057 | 0.0001 | 0.0101 | 0 | 00:00:00 |
Recent Highlights
“We’re already well into 2017 and, with so much behind us, I feel the Company is in a position to see greatly improved performance going forward,” said Mark Cola, President & CEO of Sigma Labs. “In a relatively short period of time we’ve raised much-needed growth capital, uplisted to the NASDAQ, signed several important strategic relationships, and won contracts with marquee customers such as Pratt & Whitney and Siemens. We’ve also landed a significant OEM Partner and are actively working on other business development initiatives, setting the stage for stronger growth in the quarters to come. In effect, we’ve done what we said we would do – winning new customers, joining with other leading companies to move the industry forward, and improving our balance sheet to take advantage of the opportunities to come. This year we have the wind at our backs, with unlimited potential for taking additive manufacturing to a whole new level.”
2016 Full Year Financial ResultsRevenue for the year ended December 31, 2016 was approximately $1.0 million versus approximately $1.2 million for 2015. The Company reported a net loss for the year of approximately $2.2 million, or $(0.35) per diluted share, versus a loss of approximately $1.7 million, or $(0.27) per diluted share, for 2015.
Investor Conference CallThe Company will host a conference call to discuss its 2016 full year financial results today, March 30, 2017, at 11:00 a.m. Eastern Time. To participate in the call, please dial toll free 1-844-802-2441, or 1-412-317-5134, approximately five minutes before the conference call time stated above. A live webcast of the call can also be accessed on the Sigma Labs website at www.sigmalabsinc.com. A recording will be available on the Company's website upon completion of the call.
About Sigma Labs, Inc. Sigma Labs, Inc. is a provider of quality assurance software under the PrintRite3D® brand and a developer of advanced, in-process, non-destructive quality assurance software for commercial firms worldwide seeking productive solutions for advanced manufacturing. For more information please visit us at www.sigmalabsinc.com.
Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements often contain words such as "expects," "anticipates," "intends," "believes" or "will." Our forward-looking statements are subject to a number of risks, uncertainties and assumptions that could adversely affect us, including the risks set forth in our annual report on Form 10-K. The forward-looking statements in this press release are made only as of the date of this press release. We undertake no obligation to update our forward-looking statements, whether as a result of new information, future events or otherwise.
Sigma Labs, Inc. | ||||||||||||||||||||
Condensed Statements of Operations | ||||||||||||||||||||
Three Months Ended | Twelve Months Ended | |||||||||||||||||||
Years Ended December 31 | Years Ended December 31 | |||||||||||||||||||
2016 | 2015 | 2016 | 2015 | |||||||||||||||||
REVENUE | $ | 324,192 | $ | 586,295 | $ | 966,422 | $ | 1,234,810 | ||||||||||||
COST OF REVENUE | 21,158 | 75,625 | 228,902 | 214,004 | ||||||||||||||||
GROSS PROFIT | 303,034 | 510,670 | 737,520 | 1,020,806 | ||||||||||||||||
EXPENSES: | ||||||||||||||||||||
Other General and Administration | 444,520 | 395,987 | 1,790,096 | 1,282,952 | ||||||||||||||||
Payroll Expense | 299,346 | 247,173 | 1,026,840 | 585,706 | ||||||||||||||||
Stock-Based Compensation | 105,004 | 39,938 | 341,558 | 518,438 | ||||||||||||||||
Research and Development | 4,488 | 124,009 | 92,992 | 330,554 | ||||||||||||||||
Total Expenses | 853,358 | 807,107 | 3,251,486 | 2,717,650 | ||||||||||||||||
OTHER INCOME (EXPENSE) | ||||||||||||||||||||
Interest Income | 67 | 203 | 355 | 1,340 | ||||||||||||||||
Other Income | 20,077 | - | 51,703 | - | ||||||||||||||||
Other Income-Decrease in fair value of derivative liabilities | 354,644 | - | 354,644 | - | ||||||||||||||||
Other Expense - Debt discount amortization | (89,570 | ) | - | (89,570 | ) | |||||||||||||||
Loss on Investment in Joint Venture | 105 | (670 | ) | - | (778 | ) | ||||||||||||||
Total Other Income | 285,323 | (467 | ) | 317,132 | 562 | |||||||||||||||
LOSS BEFORE PROVISION FOR INCOME TAXES | (265,001 | ) | (296,904 | ) | (2,196,834 | ) | (1,696,282 | ) | ||||||||||||
Provision for income Taxes | - | - | - | - | ||||||||||||||||
Net Loss | $ | (265,001 | ) | $ | (296,904 | ) | $ | (2,196,834 | ) | $ | (1,696,282 | ) | ||||||||
Net Loss per Common Share - Basic and Diluted | $ | (0.04 | ) | $ | (0.05 | ) | $ | (0.35 | ) | $ | (0.27 | ) | ||||||||
Weighted Average Number of Shares | ||||||||||||||||||||
Outstanding - Basic and Diluted | 6,267,577 | 6,237,511 | 6,249,609 | 6,228,108 | ||||||||||||||||
Sigma Labs, Inc. | ||||||||
Condensed Balance Sheets | ||||||||
December 31, 2016 | December 31, 2015 | |||||||
ASSETS | ||||||||
Current Assets: | ||||||||
Cash | $ | 398,391 | $ | 1,539,809 | ||||
Accounts Receivable, net | 288,236 | 280,222 | ||||||
Inventory | 187,241 | 20,129 | ||||||
Prepaid Assets | 36,056 | 38,687 | ||||||
Total Current Assets | 909,924 | 1,878,847 | ||||||
Other Assets: | ||||||||
Property and Equipment, net | 564,933 | 714,754 | ||||||
Intangible Assets, net | 226,450 | 167,644 | ||||||
Investment in Joint Venture | 500 | 9,222 | ||||||
Prepaid Stock Compensation | 167,562 | 418,547 | ||||||
Total Other Assets | 959,445 | 1,310,167 | ||||||
TOTAL ASSETS | $ | 1,869,369 | $ | 3,189,014 | ||||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||||
Current Liabilities: | ||||||||
Accounts Payable | 112,175 | 38,393 | ||||||
Notes Payable, net of original issue discount $79,886 | 561,834 | - | ||||||
Accrued Expenses | 125,116 | 71,523 | ||||||
Total Current Liabilities | 799,125 | 109,916 | ||||||
Long-Term Liabilities | ||||||||
Derivative Liability | 93,206 | - | ||||||
Total Long-Term Liablitiy | 93,206 | - | ||||||
TOTAL LIABILITIES | 892,331 | 109,916 | ||||||
Stockholders' Equity | ||||||||
Preferred Stock, $0.001 par; 10,000,000 shares authorized; | ||||||||
None issued and outstanding | - | - | ||||||
Common Stock, $0.001 par; 15,000,000 shares authorized; | ||||||||
6,267,577 and 6,239,073 issued and outstanding at | ||||||||
December 31, 2016 and 2015, respectively | 6,268 | 6,239 | ||||||
Additional Paid-In Capital | 10,731,724 | 10,636,979 | ||||||
Accumulated Deficit | (9,760,954 | ) | (7,564,120 | ) | ||||
Total Stockholders' Equity | 977,038 | 3,079,098 | ||||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY | $ | 1,869,369 | $ | 3,189,014 | ||||
Investor Relations Contact: Chris Witty cwitty@darrowir.com; 646-438-9385
1 Year Sigma Labs Chart |
1 Month Sigma Labs Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions